Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

MESO Relative to the S&P 500

MESO Relative to the Sector

Seasonal Chart Analysis

Analysis of the Mesoblast Ltd. (NASD:MESO) seasonal charts above shows that a Buy Date of December 21 and a Sell Date of March 16 has resulted in a geometric average return of 12.21% above the benchmark rate of the S&P 500 Total Return Index over the past 19 years. This seasonal timeframe has shown positive results compared to the benchmark in 15 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 19 years by an average of 21.24% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. The company was founded by Silviu Itescu on June 8, 2004 and is headquartered in Melbourne, Australia.

To download MESO seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: MESO